region stringclasses 1
value | symbol stringlengths 1 5 | exchange stringclasses 8
values | quote_type stringclasses 2
values | currency stringclasses 1
value | name stringlengths 2 84 ⌀ | sector stringclasses 12
values | industry stringclasses 148
values | close float64 0 5.92k ⌀ | volume float64 0 134M ⌀ | market_cap float64 22.4k 2,794B ⌀ | updated_at timestamp[ns] | long_business_summary stringlengths 50 5.19k ⌀ | status stringclasses 1
value | __index_level_0__ int64 0 7.31k |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
US | ZTEK | NCM | EQUITY | USD | Zentek Ltd. | Healthcare | Medical Instruments & Supplies | 1.15 | 14,198 | 116,137,344 | 2023-10-17T21:24:47.944285 | Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protec... | null | 7,301 |
US | ZTO | NYQ | EQUITY | USD | ZTO Express (Cayman) Inc. | Industrials | Integrated Freight & Logistics | 24.01 | 1,413,808 | 19,570,767,872 | 2023-10-17T21:24:53.606675 | ZTO Express (Cayman) Inc. provides express delivery and other value-added logistics services in the People's Republic of China. It offers freight forwarding services; and delivery services for e-commerce and traditional merchants, and other express service users. The company was founded in 2002 and is headquartered in ... | null | 7,302 |
US | ZTR | NYQ | EQUITY | USD | Virtus Global Dividend & Income Fund Inc. | Financial | Closed-End Fund - Equity | 4.88 | 294,636 | 229,135,328 | 2023-10-17T21:24:59.866302 | Virtus Global Dividend & Income Fund Inc. is a closed-ended balanced mutual fund launched by Virtus Investment Partners, Inc. The fund is co-managed by Virtus Investment Advisers, Inc., Kayne Anderson Rudnick Investment Management LLC and Newfleet Asset Management, LLC. It invests in the public equity and fixed income ... | null | 7,303 |
US | ZTS | NYQ | EQUITY | USD | Zoetis Inc. | Healthcare | Drug Manufacturers - Specialty & Generic | 175.18 | 1,716,299 | 80,214,835,200 | 2023-10-17T21:25:05.522080 | Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion anima... | null | 7,304 |
US | ZUMZ | NMS | EQUITY | USD | Zumiez Inc. | Consumer Cyclical | Apparel Retail | 16.86 | 288,151 | 350,408,832 | 2023-10-17T21:25:11.656491 | Zumiez Inc., together with its subsidiaries, operates as a specialty retailer of apparel, footwear, accessories, and hardgoods for young men and women. The company also offers hardgoods, including skateboards, snowboards, bindings, components, and other equipment. It operates stores in the United States, Canada, Europe... | null | 7,305 |
US | ZUO | NYQ | EQUITY | USD | Zuora, Inc. | Technology | Software - Infrastructure | 8.09 | 784,908 | 1,159,124,992 | 2023-10-17T21:25:18.471236 | Zuora, Inc., together with its subsidiaries, provides cloud-based subscription management platform that enables companies in various industries to launch, manage, and transform into a subscription business. The company offers Zuora platform that acts as an orchestration engine that allows customers quote-to-cash and re... | null | 7,306 |
US | ZURA | NCM | EQUITY | USD | Zura Bio Limited | Healthcare | Biotechnology | 6.01 | 50,190 | 257,202,832 | 2023-10-17T21:25:24.266574 | Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is i... | null | 7,307 |
US | ZVIA | NYQ | EQUITY | USD | Zevia PBC | Consumer Defensive | Beverages - Non-Alcoholic | 1.97 | 200,596 | 125,188,200 | 2023-10-17T21:25:30.492487 | Zevia PBC, a beverage company, develops, markets, sells, and distributes various carbonated and non-carbonated soft drinks in the United States and Canada. It offers soda, energy drinks, organic tea, mixers, and kidz drinks. The company offers its products through various retail channels, including grocery distributors... | null | 7,308 |
US | ZVRA | NMS | EQUITY | USD | Zevra Therapeutics, Inc. | Healthcare | Biotechnology | 4.46 | 159,931 | 164,039,008 | 2023-10-17T21:25:38.163478 | Zevra Therapeutics, Inc., a rare disease company melding science, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate... | null | 7,309 |
US | ZVSA | NGM | EQUITY | USD | ZyVersa Therapeutics, Inc. | Healthcare | Biotechnology | 0.1262 | 1,193,973 | 5,313,230 | 2023-10-17T21:25:45.859034 | ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It engages in the development of VAR 200, a cholesterol efflux mediator, which is in Phase 2a clinical trial to the treatment of multiple renal indications, ... | null | 7,310 |
US | ZWS | NYQ | EQUITY | USD | Zurn Elkay Water Solutions Corporation | Industrials | Pollution & Treatment Controls | 26.82 | 979,683 | 4,676,514,304 | 2023-10-17T21:25:52.278688 | Zurn Elkay Water Solutions Corporation engages in design, procurement, manufacture, and marketing of water management solutions in the United States, Canada, and internationally. It offers water safety and control products, including interceptors, water control and backflow, fire protection, PEX pipings and tubings, va... | null | 7,311 |
US | ZYME | NMS | EQUITY | USD | Zymeworks Inc. | Healthcare | Biotechnology | 7.05 | 347,394 | 491,743,616 | 2023-10-17T21:25:59.892828 | Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include Zanidatamab, a human epidermal growth factor receptor 2 (HER2) that is in Phase 1, Phase 2, and Phase 3 clinical trials for the t... | null | 7,312 |
US | ZYNE | NCM | EQUITY | USD | Zynerba Pharmaceuticals, Inc. | Healthcare | Drug Manufacturers - Specialty & Generic | 1.3 | 861,742 | 70,121,216 | 2023-10-17T21:26:07.155471 | Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically produced cannabidiol formulated as a pe... | null | 7,313 |
US | ZYXI | NMS | EQUITY | USD | Zynex, Inc. | Healthcare | Medical Distribution | 8.12 | 226,761 | 293,787,008 | 2023-10-17T21:26:14.863280 | Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous el... | null | 7,314 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.